Peptide medicines have the potential to treat a variety of diseases due to their high activity, specific targeting, chemical stability, and lack of non-specific or drug–drug interactions. When given orally, low physicochemical characteristics such as poor membrane permeability and low target specific activity need the development of a better peptide medication. Peptide glycosylation is a potential method for modulating the physicochemical characteristics of peptide medicines as well as peptide penetration through biological membranes. A peptide can be glycosylated in one of two ways: N-linked glycosylation or O-linked glycosylation. Glycosylation of peptide drugs improves bioactivity, selectivity, and the medicinal drug’s half-life. Moreover, product clearances, inorganic tactics by major competitors, and different glycosylated peptide applications are some of the factors propelling the global glycosylated peptide market forward.
Request for Analysis of COVID-19 Impact on Glycosylated Peptide Market –
The global glycosylated peptide market is growing due to new product releases by major players. Ixifi, a chimeric human-murine monoclonal antibody, was approved by the US Food and Drug Administration (FDA) in 2017 as a therapy for osteoarthritis, Crohn’s disease, juvenile Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and rheumatoid arthritis.
Moreover, Sumsung Bioepis’ Infliximab biosimilar candidate SB2 was approved by the Korean Ministry of Food and Drug Safety in 2016, the European Commission in 2016, the Therapeutic Goods Administration (TGA) in Australia in 2016, the US FDA in 2017, and Health Canada (HC) in Canada in 2017.
The global glycosylated peptide market is being held back by obstacles connected with biosimilar product approval and strict regulatory rules.
Alliances are being used by industry participants in the global glycosylated peptide market to expand their global footprint and product variety. GlyTech Inc., a glycosylated medicine developer, and Bachem AG, a peptide producer, engaged into a co-promotional agreement for GlyTech’s glycosylation technology in 2014. Teva Pharmaceutical Industries, an Israel-based global pharmaceutical corporation, partnered with Celltrion Inc., a Korean biopharmaceutical firm, in 2016 to market two of Celltrion’s monoclonal antibody biosimilar contenders, CT-P10, in the U.S. and Canada.
The global glycosylated peptide market is projected to develop due to increased application of glycosylated peptide. Sussex Research Laboratories Inc., a leader in glycodesign and complex carbohydrate synthesis, reported in 2015 that Glycolastin, an anti-aging glycopeptide cosmetic active, has completed effective clinical studies. In vitro studies comparing the effectiveness of Glycolastin to non-glycosylated peptides found that fibroblast secreted more structural proteins such as elastin, fibronectin, and collagens. The business intends to market Glycolastin as a cosmetic ingredient in topical anti-aging treatments.
Due to an increase in FDA-approved medicines in the area, North America is anticipated to retain a prominent position in the global glycosylated peptide market during the forecast period. Owing to the increased volume of market players and their market expansion plans, Asia Pacific is projected to rise significantly. Amgen partnered with Simcere Pharmaceutical Group in 2017 to co-develop and commercialize its biosimilar medicines, as well as four unannounced pipeline biosimilar candidates, in China for the treatment of inflammatory diseases and cancer.
Request PDF Brochure Report –
Key companies contributing in the global glycosylated peptide market are GlyTech, Inc., Bachem Holding AG, Pfizer Inc., Celltrion Inc., Teva Pharmaceutical Industries Ltd., Samsung Bioepis, and Sussex Research Laboratories Inc.
Glycosylated Peptide Market – Taxonomy
- Monoclonal Antibodies (mAbs)
- Erythropoietin (EPO)
- Other Products
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Reasons to Purchase this Report
Current and future of global Glycosylated Peptide market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
Major Point Answered in Glycosylated Peptide Market Research Study are:
What will be the progress rate of the Glycosylated Peptide Market for the conjecture period, 2020-2027?
What are the prominent factors driving the Glycosylated Peptide Market across different regions?
Who are the major vendors dominating the Glycosylated Peptide industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the Glycosylated Peptide Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027